Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.8800 (-0.52%) ($2.8800 - $2.8800) on Fri. Feb. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.67% (three month average) | RSI | 30 | Latest Price | $2.8800(-0.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.6% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) IWO(84%) SKYY(83%) ARKG(82%) QQQ(82%) | Factors Impacting CGEN price | CGEN will decline at least -1.835% in a week (0% probabilities). VIXM(-75%) VXX(-57%) UUP(-31%) EDOC(-16%) GLD(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.835% (StdDev 3.67%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.51(-464.93%) | Resistance Level | $3.24 | 5 Day Moving Average | $3.02(-4.64%) | 10 Day Moving Average | $3.09(-6.8%) | 20 Day Moving Average | $3.24(-11.11%) | To recent high | -39.9% | To recent low | 0% | Market Cap | $238m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |